Targeting a coronavirus ion channel could yield new Covid-19 drugs
Chemists discover the structures of open and closed states of the channel, which could help the development of antiviral drugs to reduce inflammation.
Chemists discover the structures of open and closed states of the channel, which could help the development of antiviral drugs to reduce inflammation.
Biology graduate student Tong Zhang has spent the last two years learning the intricacies of how bacteria protect themselves.
Aided by machine learning, scientists are working to develop a vaccine that would be effective against all SARS-CoV-2 strains.
Test that measures a person’s antibodies requires a drop of blood and takes just 10 minutes to show results.
Developed by the Singapore-MIT Alliance for Research and Technology, the assay can provide new details about the type of SARS-CoV-2 circulating in a community.
Prokaryotes can detect hallmark viral proteins and trigger cell death through a process seen across all domains of life.
Institute Professor honored for groundbreaking work in nucleic acid delivery and nanoparticles.
Using this diagnostic, doctors could avoid prescribing antibiotics in cases where they won’t be effective.
Tiny Tides is an automated fast-flow instrument that can synthesize peptide-nucleic acids in a single shot.
Using a new robotic platform, researchers can simultaneously track hundreds of microbial populations as they evolve new proteins or other molecules.
HASTS PhD student Rijul Kochhar tracks changing medical and microbial realities, and examines what they portend for society.
Paper-based blood test developed by SMART researchers can rapidly determine the presence of SARS-CoV-2 neutralizing antibodies.
Comparison of four oxidation-based cleaners suggests the devices produce their own pollutants and vary in effectiveness.
Neural network identifies synergistic drug blends for treating viruses like SARS-CoV-2.
MIT team looks at classroom configurations and offers modifications to enhance safety during Covid-19 pandemic.